Unintended Consequences: The DEA and Medications for Substance Use Treatment

from Scope of Practice · host Connecticut Certification Board

Join guest host Kapil Nayar and I as we discuss a recent Kaiser Health News article that outlines how DEA blanket enforcement efforts are harming both those who use medication to support their recovery and the local pharmacies who serve them.

Episode metadata supplied by the publisher feed · Published Dec 1, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Unintended Consequences: The DEA and Medications for Substance Use Treatment

0:00 30:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Scope of Practice?

This episode is 30 minutes long.

When was this Scope of Practice episode published?

This episode was published on December 1, 2021.

Can I download this Scope of Practice episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!